Swine influenza A vaccines, pandemic (H1N1) 2009 virus, and cross-reactivity.
作者信息
Dürrwald Ralf, Krumbholz Andi, Baumgarte Sigrid, Schlegel Michael, Vahlenkamp Thomas W, Selbitz Hans-Joachim, Wutzler Peter, Zell Roland
出版信息
Emerg Infect Dis. 2010 Jun;16(6):1029-30. doi: 10.3201/eid1606.100138.
Abstract
摘要
相似文献
1
Swine influenza A vaccines, pandemic (H1N1) 2009 virus, and cross-reactivity.
Emerg Infect Dis. 2010 Jun;16(6):1029-30. doi: 10.3201/eid1606.100138.
2
Vaccine-associated enhanced respiratory disease is influenced by haemagglutinin and neuraminidase in whole inactivated influenza virus vaccines.
J Gen Virol. 2016 Jul;97(7):1489-1499. doi: 10.1099/jgv.0.000468. Epub 2016 Mar 31.
3
A bivalent live attenuated influenza virus vaccine protects against H1N2 and H3N2 viral infection in swine.
Vet Microbiol. 2021 Feb;253:108968. doi: 10.1016/j.vetmic.2020.108968. Epub 2020 Dec 28.
4
Diagnosing swine influenza.
Vet Rec. 2015 Oct 17;177(15):400. doi: 10.1136/vr.h5523.
5
Serological survey of influenza A virus infection in Japanese wild boars (Sus scrofa leucomystax).
Microbiol Immunol. 2019 Dec;63(12):517-522. doi: 10.1111/1348-0421.12750. Epub 2019 Nov 14.
6
Antibody contributes to heterosubtypic protection against influenza A-induced tachypnea in cotton rats.
Virol J. 2008 Mar 20;5:44. doi: 10.1186/1743-422X-5-44.
7
Protection against a European H1N2 swine influenza virus in pigs previously infected with H1N1 and/or H3N2 subtypes.
Vaccine. 2003 Mar 28;21(13-14):1375-81. doi: 10.1016/s0264-410x(02)00688-6.
8
Investigations of the efficacy of European H1N1- and H3N2-based swine influenza vaccines against the novel H1N2 subtype.
Vet Rec. 2003 Jul 5;153(1):9-13. doi: 10.1136/vr.153.1.9.
9
Swine influenza virus vaccines: to change or not to change-that's the question.
Curr Top Microbiol Immunol. 2013;370:173-200. doi: 10.1007/82_2012_266.
10
[Swine influenza virus: evolution mechanism and epidemic characterization--a review].
Wei Sheng Wu Xue Bao. 2009 Sep;49(9):1138-45.
引用本文的文献
1
Long-Term Serological Investigations of Influenza A Virus in Free-Living Wild Boars () from Northern Italy (2007-2014).
Microorganisms. 2022 Sep 1;10(9):1768. doi: 10.3390/microorganisms10091768.
2
Zoonotic infection with swine A/H1N1 influenza virus in a child, Germany, June 2020.
Euro Surveill. 2020 Oct;25(42). doi: 10.2807/1560-7917.ES.2020.25.42.2001638.
3
Cocirculation of Swine H1N1 Influenza A Virus Lineages in Germany.
Viruses. 2020 Jul 15;12(7):762. doi: 10.3390/v12070762.
4
Reproductive performance of pandemic influenza A virus infected sow herds before and after implementation of a vaccine against the influenza A (H1N1)pdm09 virus.
Porcine Health Manag. 2020 Jan 23;6:4. doi: 10.1186/s40813-019-0141-x. eCollection 2020.
5
DNA vaccine based on conserved HA-peptides induces strong immune response and rapidly clears influenza virus infection from vaccinated pigs.
PLoS One. 2019 Sep 25;14(9):e0222201. doi: 10.1371/journal.pone.0222201. eCollection 2019.
6
Vaccine-mediated protection of pigs against infection with pandemic H1N1 2009 swine influenza A virus requires a close antigenic match between the vaccine antigen and challenge virus.
Vaccine. 2019 Apr 17;37(17):2288-2293. doi: 10.1016/j.vaccine.2019.02.078. Epub 2019 Mar 23.
7
Conserved HA-peptide NG34 formulated in pCMV-CTLA4-Ig reduces viral shedding in pigs after a heterosubtypic influenza virus SwH3N2 challenge.
PLoS One. 2019 Mar 1;14(3):e0212431. doi: 10.1371/journal.pone.0212431. eCollection 2019.
8
Characterization of Monoclonal Antibodies against HA Protein of H1N1 Swine Influenza Virus and Protective Efficacy against H1 Viruses in Mice.
Viruses. 2017 Aug 8;9(8):209. doi: 10.3390/v9080209.
9
European surveillance network for influenza in pigs: surveillance programs, diagnostic tools and Swine influenza virus subtypes identified in 14 European countries from 2010 to 2013.
PLoS One. 2014 Dec 26;9(12):e115815. doi: 10.1371/journal.pone.0115815. eCollection 2014.
10
Preliminary study about sublingual administration of bacteria-expressed pandemic H1N1 influenza vaccine in miniature pigs.
J Microbiol. 2014 Sep;52(9):794-800. doi: 10.1007/s12275-014-4289-4. Epub 2014 Jul 30.
本文引用的文献
1
Serologic cross-reactivity with pandemic (H1N1) 2009 virus in pigs, Europe.
Emerg Infect Dis. 2010 Jan;16(1):96-9. doi: 10.3201/eid1601.091190.
2
Pandemic influenza A(H1N1)v: human to pig transmission in Norway?
Euro Surveill. 2009 Nov 12;14(45):19406. doi: 10.2807/ese.14.45.19406-en.
3
In vitro and in vivo characterization of new swine-origin H1N1 influenza viruses.
Nature. 2009 Aug 20;460(7258):1021-5. doi: 10.1038/nature08260.
4
Pathogenesis and transmission of the novel swine-origin influenza virus A/H1N1 after experimental infection of pigs.
J Gen Virol. 2009 Sep;90(Pt 9):2119-23. doi: 10.1099/vir.0.014480-0. Epub 2009 Jul 10.
5
Influenza A (H1N1) infection in pigs.
Vet Rec. 2009 Jun 13;164(24):760-1. doi: 10.1136/vr.164.24.760.
6
Origins and evolutionary genomics of the 2009 swine-origin H1N1 influenza A epidemic.
Nature. 2009 Jun 25;459(7250):1122-5. doi: 10.1038/nature08182.
7
Antigenic and genetic characteristics of swine-origin 2009 A(H1N1) influenza viruses circulating in humans.
Science. 2009 Jul 10;325(5937):197-201. doi: 10.1126/science.1176225. Epub 2009 May 22.
Zotero 插件